Riskpilot← Back to searchSign inGet full accessAcrilex Egenvård AB
ABActiveOrg 5569816050Bunn Fridsberg 13Retail sale of other food · NACE 4727Est. 20140 employees
Revenue 2025
SEK 1,6M
-11% vs 2024
EBITDA margin
31.8%
+49% vs 2024
Equity ratio
70.7%
Financial strength
Net profit 2025
SEK 399K
+25% vs 2024
| Revenue | SEK 1,6M | -11% |
| EBITDA | SEK 522K | +49% |
| Net profit | SEK 399K | +25% |
| Total assets | SEK 1,3M | +118% |
| Equity | SEK 927K | +76% |
| Employees | 0 | — |
Legal name
Acrilex Egenvård AB
Org number
5569816050
Legal form
Aktiebolag
NACE code
4727 · Retail sale of other food
Founded
3 september 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva handel med naturmedel, kosttillskott och därmed förenlig verksamhet.
Address
Bunn Fridsberg 13
Email
pelle@acrilex.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 001 | 821 | 2 355 | 1 838 | 1 643 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 162 | 90 | −50 | 350 | 522 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 162 | 90 | −50 | 350 | 522 |
| Net financials | −6 | −12 | −27 | −15 | −20 |
| Profit before tax | 156 | 78 | −77 | 335 | 502 |
| Tax | −19 | −14 | −0 | −15 | −103 |
| Net profit | 137 | 64 | −77 | 320 | 399 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 278 | 339 | 1 292 | 603 | 1 312 |
| Equity | 221 | 285 | 209 | 528 | 927 |
| Long-term debt | 7 | 0 | 504 | 0 | 0 |
| Short-term debt | 50 | 53 | 579 | 75 | 385 |
| Total debt | 57 | 53 | 1 083 | 75 | 385 |
EBITDA margin
31.8%
This company
15.8%
Market median
+101% vs market
20212025
Equity ratio
70.7%
This company
38.2%
Market median
+85% vs market
20212025
Return on equity
43.0%
This company
18.4%
Market median
+134% vs market
20212025
Net profit margin
24.3%
This company
8.1%
Market median
+200% vs market
20212025
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
20212025
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KP | Audit | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Acrilex Holding AB
Acrilex Egenvård AB Board members of Acrilex Egenvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klas Peter Lagerqvist | Audit | 0 companies |
| David Per-Inge Larsson | Board of Directors | 0 companies |
| Karl Olov Eriksson | Board of Directors | 0 companies |
| Anna Maria Larsson | Deputy Board Member | 0 companies |